Jeremy Grantham Horizon Therapeutics Public LTD CO Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

  • $31.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$98.98 - $115.74 $18.8 Million - $21.9 Million
-189,535 Reduced 60.57%
123,376 $14.3 Million
Q2 2023

Aug 14, 2023
BUY
$96.34 - $112.38 $9.35 Million - $10.9 Million
97,052 Added 44.96%
312,911 $32.2 Million
Q1 2023

May 12, 2023
BUY
$107.32 - $113.5 $18.4 Million - $19.5 Million
171,563 Added 387.31%
215,859 $23.6 Million
Q4 2022

Feb 13, 2023
BUY
$62.39 - $113.8 $2.76 Million - $5.04 Million
44,296 New
44,296 $5.04 Million

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track Jeremy Grantham's Portfolio

Track Jeremy Grantham Portfolio

Follow Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email